Atelosteogenesis type III is a rare genetic condition that affects bone growth before birth and in infancy. It causes very short limbs, joint differences, and underdeveloped ribs and chest that doctors can see on ultrasound or X‑ray. Many people first hear about Atelosteogenesis type III when a pregnancy scan shows skeletal differences. The condition is present from birth, and severity varies, but it can be life‑threatening when the chest is too small for normal breathing. Care focuses on breathing support, careful orthopedic management, and ongoing team-based care, and genetic counseling is often recommended for families.
Overview
Atelosteogenesis type iiiSymptoms
Atelosteogenesis type III is recognized before or at birth with very short limbs, joint dislocations, and underdeveloped hands and feet. Many newborns have a small chest and breathing problems; facial differences or cleft palate may occur.
Outlook and prognosis
Many living with Atelosteogenesis type III face significant bone differences from birth, with breathing and mobility challenges that often need intensive care early on. Survival and long-term function vary widely, depending on airway support, chest development, and complications. With coordinated orthopedic, respiratory, and rehabilitation care, some children achieve improved comfort, growth, and participation in daily life.
Causes and risk factors
Atelosteogenesis type III results from FLNB gene changes, usually a new autosomal dominant mutation. Risk is highest when a parent is affected; rare germline mosaicism can cause recurrence. Environmental and lifestyle factors don’t cause it, though they may shape complications.
Genetic influences
Genetics fully determines Atelosteogenesis type III; it results from pathogenic variants in the FLNB gene. These variants disrupt skeletal development, causing the condition’s hallmark features. Inheritance is usually autosomal dominant; many cases arise from new, spontaneous variants.
Diagnosis
Doctors suspect Atelosteogenesis type III at birth from characteristic skeletal features and X-rays. Genetic testing confirms the diagnosis. Prenatal ultrasound and genetic diagnosis of Atelosteogenesis type III may be offered in high-risk pregnancies.
Treatment and drugs
Treatment for atelosteogenesis type III focuses on breathing support at birth, careful airway management, and early orthopedic care. Many children need surgeries for spine, hip, or limb alignment and customized braces, mobility aids, and physiotherapy. Ongoing monitoring guides pain control, growth support, and family counseling.
Symptoms
In atelosteogenesis type III, bone growth is altered before birth, especially in the limbs, spine, and chest, which can affect breathing, movement, and feeding soon after delivery. Early features of atelosteogenesis type III are usually recognizable at birth and sometimes during pregnancy on ultrasound. Features vary from person to person and can change over time. Doctors assess what is seen on exam and on imaging to understand how it affects daily care.
Arms and legs are much shorter than expected. This limits reach and movement during routine care and positioning. In atelosteogenesis type III, this limb difference is often visible on prenatal imaging or at birth.
Joints at the hips, knees, or elbows can be very loose or out of place at birth. This can make movement uncomfortable and reduce range of motion. Doctors may notice joints that move more than usual or do not stay aligned.
The ribcage can be small and less flexible. This may cause breathing difficulties right after birth and can be life-threatening without support. Breathing problems are a major concern in atelosteogenesis type III.
The spine may have unusual shapes or curves. This can affect posture and limit space for the lungs. Doctors may describe this as scoliosis or kyphosis.
How people usually first notice Atelosteogenesis type iii?
Families often first notice atelosteogenesis type III before or at birth, when prenatal ultrasound shows very short limbs, a small chest, and sometimes clubfeet, or when a newborn’s limbs look markedly shorter than expected. Doctors typically confirm concern right away with a physical exam and X‑rays that reveal underdeveloped bones and joint dislocations, which are hallmark first signs of atelosteogenesis type III. Because breathing can be difficult due to a small, narrow chest, some babies need immediate support, which is often the moment caregivers realize how atelosteogenesis type III is first noticed.
Types of Atelosteogenesis type iii
Atelosteogenesis type III is a rare genetic bone growth condition. Different clinical variants aren’t widely recognized beyond this single, defined subtype caused by changes in the FLNB gene, but severity and features can vary from person to person. Symptoms don’t always look the same for everyone.
No distinct variants
No distinct types of Atelosteogenesis type III are widely accepted in medical genetics. Clinicians describe variability in limb shortening, joint positioning, and chest size within the same diagnosis. This means discussions about “types of Atelosteogenesis type III” usually refer to individual differences rather than separate subtypes.
What genetics can tell you about symptoms
Some babies with specific FLNB gene changes develop very short limbs, clubfeet, and joint stiffness, while faces may look small or flattened because cartilage doesn’t form correctly. Certain variants cluster with more severe breathing problems at birth due to a narrow chest and underdeveloped lungs.
Causes and risk factors
Atelosteogenesis type III results from a change in the FLNB gene that affects bone and joint development before birth. Some risks are written in our DNA, passed down through families. Most cases happen as a new gene change in the child, not inherited from either parent. The risk of having a child with atelosteogenesis type III is higher if a parent has the condition or carries the gene change in some of their reproductive cells, but lifestyle or environment do not cause it. Healthy habits and prenatal care cannot prevent the gene change, though they can support overall pregnancy and newborn health.
Environmental and biological risk factors
Atelosteogenesis type III is present from conception, so risk relates to events around egg and sperm, not day-to-day habits. Some risks are carried inside the body, others come from the world around us. Risk factors describe what raises the chance it occurs and are different from early symptoms of Atelosteogenesis type III you might read about elsewhere.
New DNA changes become more common in sperm as men get older. This can slightly raise the chance of a pregnancy affected by Atelosteogenesis type III. The absolute risk for any one couple remains very low.
Age-related changes in eggs mainly increase chromosomal conditions. A strong link to single-gene conditions like Atelosteogenesis type III has not been shown. If there is any effect, it appears small compared with paternal age.
Significant radiation to the pelvis or whole body before conception can damage sperm or eggs. There is no proven direct connection to Atelosteogenesis type III, but it could raise the overall chance of new DNA changes.
Heavy metals or certain solvents at unsafe levels can injure reproductive cells. While regulations aim to keep exposures low, no specific association with Atelosteogenesis type III has been demonstrated.
Genetic risk factors
Changes in a single gene called FLNB are the main genetic cause, and they affect how growing bones form in the womb. Many cases result from a brand-new change in the gene, while others are inherited from a parent who carries the variant. Risk is not destiny—it varies widely between individuals. If you’re exploring the genetic causes of atelosteogenesis type iii, FLNB testing can confirm the diagnosis and clarify family risk.
FLNB gene changes: Changes in the FLNB gene are the direct cause of atelosteogenesis type III. They alter filamin B, a protein that helps cartilage cells keep their shape during bone growth. This disruption drives the severe skeletal features seen before or at birth.
Autosomal dominant inheritance: It follows an autosomal dominant pattern. If a parent carries the FLNB change, each pregnancy has a 50% (1 in 2) chance of inheriting it. Features can vary even within the same family.
De novo variants: Most people with atelosteogenesis type III have a new FLNB change that neither parent has. This arises by chance around the time of conception. When both parents test negative on blood testing, recurrence risk is usually low but not zero.
Parental mosaicism: A parent can carry the FLNB change in only some eggs or sperm (mosaicism) and appear unaffected. This hidden mosaicism raises the chance of having another child with atelosteogenesis type III. Standard blood tests may miss very low levels of mosaicism.
Variant hotspots: Harmful FLNB changes often cluster in parts of the gene that control how the protein binds to the cell’s inner framework. These specific changes tend to misdirect the protein’s activity. That helps explain why some changes lead to more severe skeletal findings.
FLNB disorder spectrum: Different FLNB changes cause a range of skeletal conditions, including Larsen syndrome, boomerang dysplasia, and atelosteogenesis type III. Where the change sits in the gene and how it alters the protein influence severity. This helps doctors provide more precise counseling.
Family history: A prior pregnancy or child with an unexplained severe skeletal condition can point to parental mosaicism. When a known FLNB change is found in a parent, the recurrence risk is 50% (1 in 2) for each pregnancy. Genetic counseling can outline testing choices for future pregnancies.
Sex and ancestry: This condition affects all sexes and ethnic backgrounds at similar rates. There is no known increased genetic risk tied to ancestry. Reported cases come from many regions worldwide.
Lifestyle risk factors
Atelosteogenesis type iii is a genetic skeletal dysplasia; lifestyle habits do not cause it, but they can influence symptoms, daily function, and complications. Understanding how lifestyle affects Atelosteogenesis type iii helps families prioritize routines that support breathing, mobility, and comfort. Below are practical lifestyle risk factors for Atelosteogenesis type iii that can worsen or ease key challenges when guided by the care team.
Consistent, gentle range‑of‑motion work can limit contractures and help maintain joint function. Skipping therapy or doing forceful stretching can increase pain, dislocations, and loss of mobility.
Supervised low‑impact movement (such as aquatic therapy or supported standing) can support circulation and breathing endurance. High‑impact or unsupervised activity increases risks of joint dislocation and fractures.
Using careful lifting and positioning techniques reduces joint dislocations and helps protect the airway and spine. Rough transfers or unsupported sitting can trigger injuries and breathing difficulties.
Adequate protein, calcium, and vitamin D supports bone and muscle health and surgical recovery. Excess calories that lead to weight gain can worsen breathing load and stress unstable joints.
Risk prevention
Atelosteogenesis type iii is a rare, genetic skeletal condition present from birth, so the condition itself cannot be prevented. Prevention focuses on planning and reducing complications before birth, at delivery, and throughout life. Some prevention is universal, others are tailored to people with specific risks. Early planning with specialists can improve breathing safety, protect bones and joints, and support growth and development.
Meeting with a genetics team can clarify how atelosteogenesis type iii happens and the chance of it occurring again. They can discuss testing options before or during a future pregnancy.
High-resolution ultrasound and, when needed, fetal MRI can flag limb and chest differences early. Doctors can look for early signs of atelosteogenesis type iii to guide delivery planning and immediate newborn care.
If a specific family variant is known, options like chorionic villus sampling or amniocentesis can test the fetus. This helps families and teams prepare for specialized care at birth.
Planning birth at a center with neonatal intensive care and pediatric airway experts lowers risks. A coordinated plan helps manage potential breathing and airway challenges right away.
Transmission
Atelosteogenesis type III is not contagious; it cannot be caught or spread through contact, air, or bodily fluids. The genetic transmission of Atelosteogenesis type III is autosomal dominant, meaning one altered copy of a gene is enough to cause the condition. If a parent is affected, each pregnancy has a 50% chance of inheriting the change, though this situation is uncommon because it’s rare for someone with severe atelosteogenesis type III to reach reproductive age. Most cases arise from a new mutation in the egg or sperm, and rarely an unaffected parent may carry the change in only some of their reproductive cells (mosaicism), which slightly increases the chance of it happening again.
When to test your genes
Atelosteogenesis type III is a rare, severe skeletal condition present from birth, so genetic testing is most helpful before or during pregnancy, or right after delivery when ultrasound or X‑rays raise suspicion. Test if there’s a family history, unexplained recurrent pregnancy loss, or prenatal findings of limb shortening. Results guide delivery planning, newborn care, and future family planning.
Diagnosis
Diagnosis of Atelosteogenesis type iii usually starts with what doctors see on prenatal scans or right after birth, then moves to imaging and genetic testing to confirm the cause. Getting a diagnosis is often a turning point toward answers and support. Because this is a rare skeletal condition, specialists look for a pattern of features on exam and X‑rays and then check for changes in a specific gene to confirm the diagnosis.
Clinicians look for very short arms and legs, a small chest, and joint positioning that can be unusual at birth. Breathing trouble right after delivery may be a key clue in Atelosteogenesis type iii. These findings help distinguish it from other skeletal conditions.
Detailed scans can show markedly shortened long bones, a narrow rib cage, and limb positioning differences as early as the second trimester. When Atelosteogenesis type iii is suspected, a high‑risk obstetrician may repeat imaging to track growth. These findings help guide next steps before delivery.
A series of X‑rays of the entire skeleton looks at bone shape, mineralization, and spine appearance. Certain patterns are highly suggestive of Atelosteogenesis type iii. These imaging findings help narrow the diagnosis.
A blood or saliva test analyzes the FLNB gene, which is commonly involved in this condition. Finding a disease‑causing change confirms the genetic diagnosis of Atelosteogenesis type iii. Results also support family counseling about recurrence risk.
Stages of Atelosteogenesis type iii
Atelosteogenesis type iii does not have defined progression stages. It is a genetic skeletal condition that is present before birth and typically identified around delivery or on prenatal imaging, so it does not unfold in stepwise phases over time. Different tests may be suggested to help confirm what’s going on, including detailed prenatal ultrasound, newborn X‑rays, and, in some cases, genetic testing to look for changes in a known gene. In practice, early signs of atelosteogenesis type iii are often seen during pregnancy scans, with diagnosis refined by specialist assessment after birth.
Outlook and prognosis
Looking ahead can feel daunting, but many living with Atelosteogenesis type III find it helpful to focus on what can be managed now and what specialists can support over time. This rare skeletal condition can involve very short limbs, joint dislocations, a small chest, and sometimes breathing challenges at birth. Early symptoms of Atelosteogenesis type III often show up in the newborn period, and the first days and weeks are critical for breathing support and careful monitoring in a neonatal unit. Doctors call this the prognosis—a medical word for likely outcomes.
The outlook is not the same for everyone, but access to experienced orthopedic, respiratory, and rehabilitation teams can significantly shape day-to-day life. The highest medical risk is in the newborn stage, when a small, stiff chest can lead to serious breathing problems; some infants may not survive this period despite intensive care. For children who stabilize after infancy, survival improves, and attention shifts to mobility, pain, and growth. With ongoing care, many people maintain comfort and function by using bracing, physical therapy, adapted seating, and, in selected cases, surgeries to improve joint position or relieve pressure.
Understanding the prognosis can guide planning and help families set realistic goals for school, home access, and transportation. Intellectual development is typically unaffected, so participation in learning and social activities can be full, with accommodations for mobility and fatigue. Talk with your doctor about what your personal outlook might look like, including which complications to watch for and how often to check lung health and spine alignment over time. Genetic testing can sometimes provide more insight into prognosis, especially when specialists are weighing the chances of breathing stability and potential surgical options.
Long-term effects
Atelosteogenesis type iii is a rare genetic skeletal condition that affects bones, joints, and breathing from birth onward. Long-term effects vary widely, with some people facing ongoing orthopedic and respiratory needs while others have milder day-to-day limitations. Many people notice small adjustments—like planning around pain flares or shorter walking distances—as they move through school, work, and family life. People often learn that early symptoms of atelosteogenesis type iii, such as breathing trouble or joint dislocations, can shape later health, mobility, and comfort over time.
Adult height typically remains well below average due to lifelong differences in bone growth. Body proportions reflect marked limb shortening.
Knees, hips, and elbows can dislocate repeatedly over the years. This can limit range of motion and make certain movements or sports difficult.
Curvature of the spine and neck instability may develop or persist. In severe cases, pressure on the spinal cord can cause weakness, numbness, or coordination problems.
A smaller chest or airway shape can lead to chronic breathing limits and recurrent respiratory infections. Breathing is often most fragile in infancy, but some limitations can continue into later life.
How is it to live with Atelosteogenesis type iii?
Living with atelosteogenesis type III often means navigating significant bone and joint differences from infancy onward, with short stature, joint stiffness or laxity, and limb shape differences that can make everyday tasks—like dressing, moving around, or handling objects—more complex. Many people need frequent medical visits, surgeries, custom braces, wheelchairs or walkers, and tailored physical and occupational therapy, which can be time‑consuming but also empowering as skills grow and pain is managed. Families, classmates, and caregivers may need to adapt homes, schools, and routines, learning safe transfer techniques and inclusive ways to play and participate so that social life and education stay on track. With coordinated care, assistive technology, and a supportive community, many find practical workarounds that protect independence and make room for joy, learning, and connection.
Treatment and drugs
Treatment for atelosteogenesis type III focuses on supportive care, easing symptoms, and preventing complications, since there’s no medicine that can change the underlying bone development. Care is usually coordinated by a team—orthopedics, pulmonology, genetics, rehabilitation, and sometimes neonatal intensive care—because many people with atelosteogenesis type III need help with breathing, feeding, and safely positioning the body, especially in infancy. Supportive care can make a real difference in how you feel day to day, and may include assisted breathing, careful airway management, treatment of chest infections, nutritional support, and pain control. As children grow, bracing, physical and occupational therapy, and, in selected cases, surgery may help with joint stability, spine or chest shape, and comfort, though goals are individualized and risks are weighed carefully. Genetic counseling is recommended for families to understand inheritance, future pregnancy options, and available resources.
Non-drug treatment
Care for Atelosteogenesis type iii focuses on breathing support, joint stability, and comfort from day one. Because early symptoms of Atelosteogenesis type iii are often identified before or at birth, teams can plan supportive care early. Non-drug treatments often lay the foundation for daily function and family well-being. Choices depend on severity, with plans tailored over time.
Newborns may need gentle breathing help, like oxygen or noninvasive ventilation. Care teams adjust support as the chest and lungs grow.
Careful head and neck positioning can keep the airway open and ease breathing. Trained staff show families safe sleep and feeding positions.
Soft casts or custom braces can help align feet, knees, or wrists. This may improve comfort and make later surgeries, if needed, easier.
Gentle range-of-motion work helps protect joints and prevent stiffness. Therapists tailor exercises to Atelosteogenesis type iii to avoid strain.
Your genes may have an impact on how drugs work for you
Even with a rare skeletal condition like atelosteogenesis type III, genes can shape how your body absorbs, breaks down, and responds to medications for pain, infections, or surgery. Variants in drug‑processing enzymes and receptors may affect dose needs and side‑effect risks.
Pharmacological treatments
Medicines for atelosteogenesis type iii focus on easing symptoms and preventing complications, since no drug can change the underlying bone growth pattern. Early symptoms of atelosteogenesis type iii often involve breathing and joint limitations, so treatments usually target pain, lungs, and nutrition. Not everyone responds to the same medication in the same way. Your care team will tailor choices by age, severity, and what’s happening day to day.
Acetaminophen (paracetamol) or ibuprofen can help with day-to-day aches from stiff joints or after procedures. Doses are carefully adjusted by weight and age, and stomach or liver safety is monitored.
Albuterol/salbutamol via nebulizer or inhaler may ease wheeze or tight breathing during colds. Inhaled budesonide or a short, doctor‑guided course of dexamethasone may be used if airway swelling is a problem.
Palivizumab can lower the risk of severe RSV in high‑risk infants during RSV season. Prompt antibiotics like amoxicillin‑clavulanate or azithromycin are used if a bacterial chest infection is suspected.
Omeprazole or famotidine can reduce acid reflux that sometimes worsens breathing and sleep. Thickened feeds or timing of meals often work alongside these medicines.
Genetic influences
Atelosteogenesis type III is strongly linked to changes in a single gene called FLNB, which helps guide early bone and cartilage growth. A change in a gene (mutation or variant) can sometimes affect health, and in this condition it disrupts how the skeleton forms before birth. Most cases happen because of a new change in FLNB that starts in the child and isn’t inherited from either parent (de novo). If a parent does carry the FLNB change, the pattern is autosomal dominant, so each pregnancy has a 1 in 2 (50%) chance of inheriting it. Very rarely, a parent with no signs may have the change only in some egg or sperm cells (germline mosaicism), which means there can still be a small chance it happens again. Because the change is present from conception, early symptoms of Atelosteogenesis type III are often seen on prenatal ultrasound, and genetic testing of the FLNB gene can confirm the diagnosis and help with future planning.
Is Atelosteogenesis type iii genetic?
Genetics fully determines Atelosteogenesis type III; it results from pathogenic variants in the FLNB gene. These variants disrupt skeletal development, causing the condition’s hallmark features. Inheritance is usually autosomal dominant; many cases arise from new, spontaneous variants.
Pharmacogenetics—how genetics influence drug effects
In atelosteogenesis type III, changes in a gene called FLNB shape how the skeleton develops, which in turn guides treatment choices. There isn’t a medicine that fixes the gene change yet, so care focuses on breathing support, careful anesthesia for procedures, orthopedic surgery, and steady pain control when needed. Knowing the exact genetic diagnosis alerts the team to issues that matter for medicines and procedures, like a small jaw, a narrow chest, or a potentially unstable neck that can make anesthesia and airway management more complex.
Beyond these anatomic considerations, other genes can influence how someone responds to common medicines used during and after care for atelosteogenesis type III—especially pain relievers and anti‑nausea drugs. Genetic testing can sometimes identify how your body processes particular pain medicines, which helps doctors choose a drug and dose that’s more likely to work and less likely to cause side effects. Anesthesia plans are tailored more to your airway and spine than to drug–gene results, but your team may still use this information to fine‑tune post‑procedure pain relief and avoid medicines that have caused problems before. Tell your care team about any strong past reactions or lack of benefit, since genes are only part of the picture and your experience guides day‑to‑day decisions.
Interactions with other conditions
Day-to-day, breathing and airway challenges in atelosteogenesis type iii can be pushed harder by common respiratory infections like colds, flu, or RSV, which may lead to more serious breathing trouble than expected. When early symptoms of atelosteogenesis type iii include a small, stiff chest or a floppy airway, colds can linger, and repeated infections can increase the risk of pneumonia or the need for hospital care. Doctors call it a “comorbidity” when two conditions occur together. Sleep apnea, chest wall stiffness, or a curved spine can combine to limit lung expansion; reflux or swallowing difficulties can add to this by sending small amounts of fluid into the lungs, raising the chance of aspiration and infection. Instability in the upper spine or a narrow spinal canal means that head-and-neck injuries, vigorous manipulation, or conditions that already press on the spinal cord can heighten the risk of weakness, pain, or numbness, so anesthesia and any surgery require extra planning. There is also overlap with other conditions caused by changes in the same gene, so some features may resemble Larsen syndrome or related skeletal diagnoses, and coordinated care helps align breathing, feeding, spine, and orthopedic plans.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and midwives once noticed newborns with very short limbs and small chests who struggled to breathe, and some did not survive the first days. Generations remembered relatives with severe limb differences who lived only briefly, while others with milder features grew into childhood with ongoing bone and joint needs. Community stories often described the condition without a name, focusing on the fragile bones and the intense care required at birth.
First described in the medical literature as a severe skeletal dysplasia with markedly shortened arm and leg bones, atelosteogenesis type III was initially grouped with a few similar conditions seen in newborns. Early doctors relied on careful physical exams and X‑rays to tell these conditions apart, noting differences in the shape of the thigh bones, the wrists and ankles, and the size of the ribcage. In those early reports, many babies had life‑limiting breathing problems because the chest could not expand well.
From these first observations, specialists recognized that atelosteogenesis type III could look different from one child to the next. Some had very soft, under‑ossified bones at birth; others had more bone hardening but still severe limb shortening. Over time, descriptions became more precise, and patterns such as joint dislocations, clubfeet, and differences in the spine were recorded as key features doctors might see on exam or imaging.
Advances in genetics later clarified that atelosteogenesis type III is related to changes in a gene that helps build cartilage, the tissue that forms the early template for bones. This discovery helped explain why the earliest symptoms of atelosteogenesis type iii show up before birth on ultrasound, and why bone growth and joint formation are so affected. It also showed why this condition overlaps with a few other cartilage‑related skeletal disorders that share some features but follow different courses.
With each decade, the medical community improved supportive care for newborns with small chests and breathing difficulty, including planned deliveries at centers that can provide immediate respiratory support. Imaging techniques became more detailed, allowing clearer distinctions between atelosteogenesis type III and related conditions. Genetic testing offered families more definitive answers and helped guide counseling about recurrence risk in future pregnancies.
Despite evolving definitions, the core picture of atelosteogenesis type III has stayed consistent: a rare skeletal condition with significant limb shortening and variable bone hardening that can cause serious breathing issues at birth. Knowing the condition’s history helps explain why doctors still combine hands‑on examination, specialized imaging, and genetic testing to reach a diagnosis and plan early care.